NJTC Venture Fund Select Portfolio Investments March 2014 Agenda - PowerPoint PPT Presentation

NJTC Venture Fund Select Portfolio Investments March 2014

Agenda • NJTC Venture Fund Profile • Representative Investments – seek partners – CytoSorbents – IntraCellular Therapies – IntegriChain – InstaMed – Amber Road • Woomera Partners – Acquisition Criteria

NJTC Venture Fund • $80 million regional venture investor • No new investments • Latter stage of fund life • Seek partner and ultimately exit opportunities for portfolio

CytoSorbents (www.cytosorbents.com) • Extra-corporal blood filter – broad medical applicability – Cardio pulmonary bypass – Sepsis – Blood transfusion – Drug absorption in case of overdose – Contrast agents for chemotherapy and imaging – Pancreatitis, burn, trauma • $2.4 million revenue in 2013 following CE Mark • 30 investigator-led trials (unsponsored by company) in Europe • Seek partner to co-develop each indication

IntraCellular Therapies (www.IntraCellularTherapies.com) • Biotech developer of central nervous system therapeutics – Schizophrenia, Depression, Bi-polar – Parkinsons, Dementia, Autism • Nobel Laureate co-founder • Deep pipeline at phase I, II, III or pre-clinical • Compelling recent success of phase II schizophrenia compound • Seek corporate partner to co-develop assets

IntegriChain (www.IntegriChain.com) • Provider of cloud-based data analytics to drug industry • Customers include two-thirds of largest big pharma and biotech • Product applicable to other industries with complex supply chain – Consumer packaged goods, Books & Publishing, Retail, Food & Beverage • Seek partners for further expansion into healthcare plus growth in non Life Sciences

InstaMed (www.InstaMed.com) • Software platform accelerates collection of provider payments • Processed billions of dollars in claims and remittances in 2013 • Expanding network of payors, health IT vendors and financial institutions

Amber Road (www.AmberRoad.com) • SaaS global trade software applications • Customers include GE, Monsanto, Walmart • Geographic penetration – S Africa – Asia – Europe Source: WTO Statistics, 2013

Woomera Partners (www.WoomeraPartners.com) • Recently launched to acquire health technology and health services companies • $50 million revenue ideal – target ranges from $20 million - $70 million • Corporate divestitures, independently owned, VC or PE backed